1
|
Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c.
|
J Cell Sci
|
2005
|
1.85
|
2
|
The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells.
|
J Biol Chem
|
2006
|
1.68
|
3
|
Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells.
|
Carcinogenesis
|
2008
|
1.49
|
4
|
FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression.
|
J Biol Chem
|
2008
|
1.19
|
5
|
Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1.
|
Methods Mol Biol
|
2010
|
0.97
|
6
|
Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade.
|
BMC Cancer
|
2013
|
0.96
|
7
|
A 3D collagen microsphere culture system for GDNF-secreting HEK293 cells with enhanced protein productivity.
|
Biomaterials
|
2007
|
0.94
|
8
|
Targeted inactivation of kinesin-1 in pancreatic β-cells in vivo leads to insulin secretory deficiency.
|
Diabetes
|
2010
|
0.93
|
9
|
FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c.
|
Front Oncol
|
2013
|
0.91
|
10
|
Identification and characterization of human VCY2-interacting protein: VCY2IP-1, a microtubule-associated protein-like protein.
|
Biol Reprod
|
2003
|
0.91
|
11
|
A multi PDZ-domain protein Pdzd2 contributes to functional expression of sensory neuron-specific sodium channel Na(V)1.8.
|
Mol Cell Neurosci
|
2009
|
0.89
|
12
|
Identification of cis-elements for ethylene and circadian regulation of the Solanum melongena gene encoding cysteine proteinase.
|
Plant Mol Biol
|
2005
|
0.89
|
13
|
Proteolytic cleavage of PDZD2 generates a secreted peptide containing two PDZ domains.
|
EMBO Rep
|
2003
|
0.88
|
14
|
Correlated evolution of transcription factors and their binding sites.
|
Bioinformatics
|
2011
|
0.87
|
15
|
Melatonin MT1 receptor-induced transcriptional up-regulation of p27(Kip1) in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF-κB): potential implications on prostate cancer chemoprevention and therapy.
|
J Pineal Res
|
2012
|
0.85
|
16
|
Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance.
|
J Pineal Res
|
2008
|
0.84
|
17
|
Reduced expression of AMPK-β1 during tumor progression enhances the oncogenic capacity of advanced ovarian cancer.
|
Mol Cancer
|
2014
|
0.84
|
18
|
Signaling mechanisms of melatonin in antiproliferation of hormone-refractory 22Rv1 human prostate cancer cells: implications for prostate cancer chemoprevention.
|
J Pineal Res
|
2007
|
0.84
|
19
|
VCY2 protein interacts with the HECT domain of ubiquitin-protein ligase E3A.
|
Biochem Biophys Res Commun
|
2002
|
0.84
|
20
|
The coactivator Bridge-1 increases transcriptional activation by pancreas duodenum homeobox-1 (PDX-1).
|
Mol Cell Endocrinol
|
2005
|
0.83
|
21
|
Interactions with p300 enhance transcriptional activation by the PDZ-domain coactivator Bridge-1.
|
J Endocrinol
|
2005
|
0.83
|
22
|
The autocrine human secreted PDZ domain-containing protein 2 (sPDZD2) induces senescence or quiescence of prostate, breast and liver cancer cells via transcriptional activation of p53.
|
Cancer Lett
|
2008
|
0.82
|
23
|
G-box binding coincides with increased Solanum melongena cysteine proteinase expression in senescent fruits and circadian-regulated leaves.
|
Plant Mol Biol
|
2003
|
0.80
|
24
|
Signal transduction of receptor-mediated antiproliferative action of melatonin on human prostate epithelial cells involves dual activation of Gα(s) and Gα(q) proteins.
|
J Pineal Res
|
2010
|
0.79
|
25
|
The roles of the PDZ-containing proteins bridge-1 and PDZD2 in the regulation of insulin production and pancreatic beta-cell mass.
|
Curr Protein Pept Sci
|
2009
|
0.78
|
26
|
Secreted PDZD2 exerts concentration-dependent effects on the proliferation of INS-1E cells.
|
Int J Biochem Cell Biol
|
2005
|
0.76
|